Krystal Biotech, Inc.

KRYS · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
164
SEC Filings

Business Summary

PART I . Overview We are a fully integrated, global, commercial-stage biotechnology company focused on the discovery, development, manufacturing and commercialization of genetic medicines to treat diseases with high unmet medical needs. Using our patented gene therapy technology platform that is based on engineered herpes simplex virus-1 (HSV-1), we create vectors that efficiently deliver therapeutic transgenes to cells of interest in multiple organ systems. The cells own machinery then transcri...

Next Earnings

Q2 FY2026 — expected 2026-08-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionKRYSdiscussed_in_filing Cybersecurity
topic_mentionKRYSdiscussed_in_filing Trusted Computing
topic_mentionKRYSdiscussed_in_filing Blockchain & Crypto
topic_mentionKRYSdiscussed_in_filing Regulation
topic_mentionKRYSdiscussed_in_filing Healthcare & Bio
topic_mentionKRYSdiscussed_in_filing Platform & Ecosystem
topic_mentionKRYSdiscussed_in_filing Sovereign & Government
topic_mentionKRYSdiscussed_in_filing Cybersecurity
topic_mentionKRYSdiscussed_in_filing Trusted Computing
topic_mentionKRYSdiscussed_in_filing Blockchain & Crypto
topic_mentionKRYSdiscussed_in_filing Regulation
topic_mentionKRYSdiscussed_in_filing Healthcare & Bio
topic_mentionKRYSdiscussed_in_filing Platform & Ecosystem
topic_mentionKRYSdiscussed_in_filing Sovereign & Government
topic_mentionKRYSdiscussed_in_filing Cybersecurity
topic_mentionKRYSdiscussed_in_filing Trusted Computing
topic_mentionKRYSdiscussed_in_filing Blockchain & Crypto
topic_mentionKRYSdiscussed_in_filing Regulation
topic_mentionKRYSdiscussed_in_filing Healthcare & Bio
topic_mentionKRYSdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-172025-12-310001711279-26-000016EDGAR86K words
2025-02-192024-12-310001711279-25-000008EDGAR
2024-02-262023-12-310001711279-24-000005EDGAR
2023-02-272022-12-310001711279-23-000008EDGAR
2022-02-282021-12-310001711279-22-000004EDGAR
2021-03-012020-12-310001711279-21-000006EDGAR
2020-03-102019-12-310001564590-20-009550EDGAR
2019-03-122018-12-310001564590-19-007267EDGAR
2018-03-122017-12-310001564590-18-005252EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-032025-09-300001711279-25-000087EDGAR19K words
2025-08-042025-06-300001711279-25-000077EDGAR
2025-05-062025-03-310001711279-25-000044EDGAR
2024-11-042024-09-300001711279-24-000056EDGAR
2024-08-052024-06-300001711279-24-000040EDGAR
2024-05-062024-03-310001711279-24-000020EDGAR
2023-11-062023-09-300001711279-23-000073EDGAR
2023-08-072023-06-300001711279-23-000064EDGAR
2023-05-082023-03-310001711279-23-000029EDGAR
2022-11-072022-09-300001711279-22-000058EDGAR
2022-08-082022-06-300001711279-22-000047EDGAR
2022-05-092022-03-310001711279-22-000016EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-170001711279-26-000018EDGAR4K words
2026-01-120001711279-26-000008EDGAR
2026-01-080001711279-26-000005EDGAR
2025-12-230001711279-25-000092EDGAR
2025-11-030001711279-25-000088EDGAR
2025-10-220001711279-25-000082EDGAR
2025-08-040001711279-25-000078EDGAR
2025-07-250001711279-25-000071EDGAR
2025-07-240001711279-25-000069EDGAR
2025-07-090001711279-25-000065EDGAR

164 total filings indexed. 133 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001711279
TickerKRYS
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 256e1e33f13c5634d044b50b14a16fd4b6a01cd450aecb3fda02377f20e4abd6
parent: 95d0f54f3638dd49114e36f730031c0f1cba007b74f57919b57ada97982e1206
content hash: a417e19a1c8d82033f3124c791b54502c9fdbe04225940178a42c3f822b877d0
signed: 2026-04-13T04:45:56.273Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf